Experienced Management of Global Endocrinology Studies
At SPRI Clinical Trials we understand the regulatory hurdles inherent in global endocrinology studies, and employ a dedicated team of feasibility experts to proactively identify issues and mitigate risks. Patient safety, particularly cardiovascular risk, is of utmost concern with these therapies. Because of these associated risks, large-scale international clinical endocrinology studies are often required to yield positive statistical results in order to obtain regulatory approval.
Our clinical endocrinology professionals diligently stay abreast of the ever-changing regulatory guidance related to this field of clinical research. Partner with SPRI to design and execute your Phase I – IV growth hormone and diabetes studies — put our expertise to work for you.